/ Print /


Four risks healthcare executives should monitor in 2018With the right preventions in place, hospitals and healthcare executives will be well positioned to respond to these four risks in 2018.
Three ways to make healthcare consumers happierA new survey has eye-opening findings about the status quo one-size-fits-all health plan.
New high blood pressure guideline healthcare cost impactFifty percent of Americans have high blood pressure, per new guidelines. Here’s how those guidelines could affect medication utilization and healthcare spending.
Five key elements of successful local initiatives to combat the opioid crisisSuccessful community initiatives are creating systems of care that bridge multiple programs to provide coordinated services to individuals with substance use disorders. Here are five.
Three things health execs need to know about CAR T-cell therapyHere’s your quick guide to understanding how CAR T-cell therapy could affect patients and payers.
What oncologists say about new cancer treatment optionsA new report from Cardinal Health Specialty Solutions gives behind-the-scenes perspectives from oncologists about CAR-T cell therapies, biosimilars and AML therapies (or genomic medicines)
Link between nutrition and COPD: What health execs should knowSimple strategies can improve the nutritional well-being of COPD patients and help them maintain their weight.
Unique clinic-pharmacy collaboration benefits hepatitis C patientsA Walgreens study sheds light on the benefits of patient-centered pharmacy-based programs.
Four therapeutic areas to watch in 2018
Four therapeutic areas to watch in 2018Prepare for major pipeline developments in diabetes, autoimmune disorders, oncology, and COPD.
How one project will change the way value is measured in healthcareThe Innovation and Value Initiative's Mark Linthicum talks to Managed Healthcare Executive (MHE) a new tool to better measure value in healthcare treatments.